Elevation Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 5.99 M | $3.60 M | 102.58% | 10.14% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 4.76 M | $2.86 M | 55.56% | 8.05% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.99 M | $2.39 M | 691.16% | 6.75% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.53 M | $2.12 M | -1.97% | 5.97% |
| VANGUARD GROUP INC | 11/13/2024 | 3.07 M | $1.84 M | 60.22% | 5.20% |
| BVF INC/IL | 11/14/2024 | 2.97 M | $1.78 M | 28.31% | 5.02% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.91 M | $1.74 M | 100.00% | 4.92% |
| AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 2.83 M | $1.70 M | 0.00% | 4.80% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.79 M | $1.07 M | 100.00% | 3.02% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 1.36 M | $815,412 | -43.31% | 2.30% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 1.30 M | $778,728 | -27.89% | 2.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.11 M | $666,038 | 7.61% | 1.88% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 1.08 M | $647,749 | 227.20% | 1.83% |
| STATE STREET CORP | 11/14/2024 | 1.02 M | $610,714 | 13.49% | 1.72% |
| MORGAN STANLEY | 11/14/2024 | 951,089 | $570,559 | -25.32% | 1.61% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 941,275 | $564,671 | 0.00% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 785,450 | $471,191 | 100.00% | 1.33% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 690,089 | $413,984 | 0.00% | 1.17% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 652,188 | $390,000 | 100.00% | 1.10% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 543,300 | $325,925 | 40.61% | 0.92% |
| BRAIDWELL LP | 11/14/2024 | 473,503 | $284,054 | -80.89% | 0.80% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 440,489 | $264,249 | 211.68% | 0.75% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 433,545 | $260,000 | 100.00% | 0.73% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 215,984 | $129,569 | 263.27% | 0.37% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 183,493 | $110,077 | 0.00% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 174,137 | $104,465 | 114.49% | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 161,422 | $96,837 | 100.00% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 128,000 | $76,787 | 0.00% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 124,181 | $74,496 | -7.70% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 123,840 | $74,292 | -19.37% | 0.21% |
| MILLINGTON FINANCIAL ADVISORS, LLC | 10/15/2024 | 100,000 | $59,990 | 100.00% | 0.17% |
| BARCLAYS PLC | 11/19/2024 | 72,077 | $43,000 | 302.44% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 64,606 | $38,760 | -0.47% | 0.11% |
| JPMORGAN CHASE & CO | 12/26/2024 | 61,334 | $36,795 | 175.87% | 0.10% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 57,100 | $34,254 | 100.00% | 0.10% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 45,907 | $28,000 | 100.00% | 0.08% |
| UBS GROUP AG | 11/14/2024 | 42,590 | $25,554 | 169.06% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 39,877 | $23,886 | -78.30% | 0.07% |
| JANE STREET GROUP, LLC | 11/15/2024 | 29,668 | $17,798 | -40.81% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 27,895 | $16,734 | -0.61% | 0.05% |
| CITADEL ADVISORS LLC | 11/14/2024 | 27,600 | $16,557 | 1,214.29% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 26,688 | $16,010 | 100.00% | 0.05% |
| INVESCO LTD. | 11/12/2024 | 24,346 | $14,606 | -0.88% | 0.04% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 19,500 | $11,000 | 100.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 19,166 | $11,498 | 0.10% | 0.03% |
| PALUMBO WEALTH MANAGEMENT LLC | 10/28/2024 | 17,515 | $10,508 | 55.47% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 16,841 | $11,000 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 13,677 | $8,206 | 24.34% | 0.02% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 13,631 | $8,177 | 100.00% | 0.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 12,240 | $7,343 | -86.69% | 0.02% |
Elevation Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Elevation Oncology, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 5.99 M
TANG CAPITAL MANAGEMENT LLC: 4.76 M
GOLDMAN SACHS GROUP INC: 3.99 M
FARALLON CAPITAL MANAGEMENT LLC: 3.53 M
VANGUARD GROUP INC: 3.07 M
BVF INC/IL: 2.97 M
77.72% of Elevation Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 47.99 M shares in the last 24 months. This purchase volume represents approximately $37.43 M in transactions.